Toll-like receptor 4 gene polymorphism influences dendritic cell in vitro function and clinical outcomes in vaccinated melanoma patients

dc.date.accessioned2016-11-29T18:35:59Z
dc.date.available2016-11-29T18:35:59Z
dc.date.created2016-11-29T18:35:59Z
dc.date.issued2012
dc.identifier0340-7004
dc.identifierhttp://hdl.handle.net/10533/127629
dc.identifier1090238
dc.identifierWOS:000310888400016
dc.languageeng
dc.publisherSPRINGER
dc.relationhttps://doi.org/10.1007/s00262-012-1268-7
dc.relation10.1007/s00262-012-1268-7
dc.relationinfo:eu-repo/grantAgreement/Fondecyt/1090238
dc.relationinfo:eu-repo/semantics/dataset/hdl.handle.net/10533/93477
dc.relationinstname: Conicyt
dc.relationreponame: Repositorio Digital RI2.0
dc.relationinstname: Conicyt
dc.relationreponame: Repositorio Digital RI2.0
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleToll-like receptor 4 gene polymorphism influences dendritic cell in vitro function and clinical outcomes in vaccinated melanoma patients
dc.typeArticulo


Este ítem pertenece a la siguiente institución